Jorge A. Leon
Chief Science OfficerDr. Jorge A. Leon, Ph.D., serves as Chief Science Officer at Todos Medical Ltd. At Todos Medical Ltd, he also served as Chief Medical Advisor since July 2019. He also serves as Specialist Advisor of HealthPro BioVentures LLC, Advisor of Noblegen Biosciences, Inc., Chairman and Member of the Scientific Advisory Board at AltheaDx, Inc. since April 29, 2009, Member of the Advisory Board at USDS, Inc., and Member of the Advisory Board at ParagonDx LLC since February 2009. He served as a Strategic Partner at Evolution Venture Partners LLC until October 2026, where he headed the Molecular Diagnostics activities. Dr. Leon was employed at Evolution Venture Partners LLC until October 2026. He served as Senior Strategic Advisor of Foundation Medicine, Inc. and as a Member of the Advisory Board at Correlogic Systems, Inc. He served as Chief Scientific Officer, Scientific Advisor, Vice President of Business Development, and Director at Orion Genomics, LLC, joining in July 2005. In 2003, he founded Leomics Associates, Inc. He also served as Senior Vice President of Business Development and Chief Scientific Officer at NEN Life Sciences. In the early 1990s, he transitioned into industry and played a role in establishing and leading the molecular diagnostics laboratories at Quest Diagnostics. At the company, he served as Vice President of Applied Genomics, Senior Director of Biotechnology Development, and Director of Molecular Diagnostics over a twelve-year tenure. He is internationally recognized for his pioneering work in molecular diagnostics. He specialized in identifying breakthrough opportunities and industry trends and helps start-up businesses, academic centers, and established companies build and commercialize innovative business strategies, product pipelines, and test menus. His academic research at Columbia University focused on developing monoclonal antibody-based tumor marker assays and radio-immuno imaging devices. He holds a Ph.D. in Cellular and Molecular Biology from New York University and completed his postdoctoral studies at the German Cancer Research Center and Columbia University.
Positions
- Company NameTodos Medical Ltd.Stock CodeTOMDFPositionChief Science OfficerColleagues
